Paul De Munter

3.2k total citations
56 papers, 869 citations indexed

About

Paul De Munter is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Paul De Munter has authored 56 papers receiving a total of 869 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Infectious Diseases, 20 papers in Epidemiology and 10 papers in Surgery. Recurrent topics in Paul De Munter's work include HIV Research and Treatment (8 papers), HIV/AIDS Research and Interventions (8 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). Paul De Munter is often cited by papers focused on HIV Research and Treatment (8 papers), HIV/AIDS Research and Interventions (8 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). Paul De Munter collaborates with scholars based in Belgium, United States and Netherlands. Paul De Munter's co-authors include Eric Van Wijngaerden, Willy Peetermans, Isabel Spriet, Willem‐Jan Metsemakers, Melissa Depypere, Steven Vanderschueren, Daniël Knockaert, Jan Verhaegen, Stefaan Nijs and Stefanie Desmet and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and AIDS.

In The Last Decade

Paul De Munter

48 papers receiving 848 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul De Munter Belgium 18 411 300 159 150 145 56 869
Niccolò Riccardi Italy 20 610 1.5× 307 1.0× 99 0.6× 167 1.1× 50 0.3× 102 1.0k
Mary Bavaro United States 20 522 1.3× 635 2.1× 190 1.2× 190 1.3× 35 0.2× 35 1.3k
Daniel B. Chastain United States 18 474 1.2× 493 1.6× 132 0.8× 80 0.5× 27 0.2× 109 1.1k
Olivier Clerc Switzerland 23 308 0.7× 450 1.5× 70 0.4× 294 2.0× 27 0.2× 80 1.7k
Rick L. Pesano United States 13 407 1.0× 668 2.2× 253 1.6× 47 0.3× 43 0.3× 19 1.1k
Mathurin Cyrille Tejiokem Cameroon 18 481 1.2× 386 1.3× 206 1.3× 92 0.6× 24 0.2× 69 815
Colin Menezes South Africa 15 516 1.3× 264 0.9× 122 0.8× 247 1.6× 45 0.3× 62 946
Martin Wiselka United Kingdom 20 507 1.2× 529 1.8× 87 0.5× 121 0.8× 29 0.2× 61 1.1k
Joaquín Burgos Spain 19 367 0.9× 670 2.2× 331 2.1× 167 1.1× 17 0.1× 82 1.2k
Ana González-Cordón Spain 17 459 1.1× 215 0.7× 237 1.5× 80 0.5× 28 0.2× 73 903

Countries citing papers authored by Paul De Munter

Since Specialization
Citations

This map shows the geographic impact of Paul De Munter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul De Munter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul De Munter more than expected).

Fields of papers citing papers by Paul De Munter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul De Munter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul De Munter. The network helps show where Paul De Munter may publish in the future.

Co-authorship network of co-authors of Paul De Munter

This figure shows the co-authorship network connecting the top 25 collaborators of Paul De Munter. A scholar is included among the top collaborators of Paul De Munter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul De Munter. Paul De Munter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gilissen, Liesbeth, Peter Declercq, Willy Peetermans, et al.. (2026). Clinical Outcome Associated With Beta‐Lactam Allergy Labels in Hospitalized Patients in Belgium. Clinical and Translational Allergy. 16(4). e70166–e70166.
2.
Beckhoven, Dominique Van, Rémy Demeester, Jens Van Praet, et al.. (2025). Dual cross‐sectional and longitudinal perspective on the continuum of HIV care to disentangle natural epidemic evolution from real progress, Belgium 2014–2022. HIV Medicine. 26(7). 1034–1045.
4.
Elslande, Jan Van, Pieter Vermeersch, Glynis Frans, et al.. (2024). IFN-α2 Autoantibody Screening and Functional Evaluation in Viral and Bacterial Infections. The Journal of Applied Laboratory Medicine. 9(6). 977–989. 1 indexed citations
5.
Praet, Jens Van, Ben Serrien, Gilles Darcis, et al.. (2023). Dynamics of Weight Change After Initiation of Contemporaneous Antiretroviral Therapy in Treatment-Naive HIV-1 Infected Patients: Results From the Belgian HIV Cohort 2015–2021. JAIDS Journal of Acquired Immune Deficiency Syndromes. 93(2). e4–e5.
6.
Noppen, Sam, Dominique Schols, Paul De Munter, et al.. (2023). FLUIDOT: A Modular Microfluidic Platform for Single‐Cell Study and Retrieval, with Applications in Drug Tolerance Screening and Antibody Mining. Small Methods. 7(3). e2201477–e2201477. 2 indexed citations
7.
Depypere, Melissa, et al.. (2023). Should treatment decisions in septic arthritis of the native hip joint be based on the route of infection?. Journal of Bone and Joint Infection. 8(5). 209–218. 2 indexed citations
8.
Engelen, Matthias M., Christophe Vandenbriele, Bert Vandenberk, et al.. (2022). Thromboprophylaxis in COVID‐19: Weight and severity adjusted intensified dosing. Research and Practice in Thrombosis and Haemostasis. 6(3). e12683–e12683. 4 indexed citations
9.
laer, Eva Van, Greet De Vlieger, Rik Schrijvers, et al.. (2022). Overall performance of a drug–drug interaction clinical decision support system: quantitative evaluation and end-user survey. BMC Medical Informatics and Decision Making. 22(1). 48–48. 29 indexed citations
10.
Onsea, Jolien, Saartje Uyttebroek, Jeroen Wagemans, et al.. (2021). Bacteriophage Therapy for Difficult-to-Treat Infections: The Implementation of a Multidisciplinary Phage Task Force (The PHAGEFORCE Study Protocol). Viruses. 13(8). 1543–1543. 32 indexed citations
11.
Coenen, Sofie, Paul De Munter, Maja Noman, et al.. (2017). Effects of Education and Information on Vaccination Behavior in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 23(2). 318–324. 31 indexed citations
12.
Vanderbeke, Lore, Willy Peetermans, Veroniek Saegeman, & Paul De Munter. (2016). Q fever: a contemporary case series from a Belgian hospital. Acta Clinica Belgica. 71(5). 290–296. 4 indexed citations
13.
Munter, Paul De, Inge Derdelinckx, Jan Verhaegen, et al.. (2015). Characteristics, causes, and outcome of 54 episodes of bloodstream infections in a cohort of HIV patients. Infectious Diseases. 47(9). 611–617. 8 indexed citations
14.
Munter, Paul De, Pascal Van Bleyenbergh, Walter De Wever, et al.. (2013). Tuberculosis infection following anti-TNF therapy in inflammatory bowel disease, despite negative screening. Journal of Crohn s and Colitis. 8(6). 550–557. 28 indexed citations
15.
Munter, Paul De, et al.. (2013). A 75-YEAR-OLD MISSIONARY WITH FEVER, SPLENOMEGALY AND PANCYTOPENIA. Acta Clinica Belgica. 68(3). 225–228. 1 indexed citations
16.
Thai, Sopheak, Olivier Koole, Paul De Munter, et al.. (2009). Five‐year experience with scaling‐up access to antiretroviral treatment in an HIV care programme in Cambodia. Tropical Medicine & International Health. 14(9). 1048–1058. 39 indexed citations
17.
Munter, Paul De & Willy Peetermans. (2008). Wijzigingen in de richtlijnen voor endocarditisprofylaxe. Tijdschrift voor Geneeskunde. 1(5). 219–224. 1 indexed citations
18.
Laethem, Kristel Van, Yoeri Schrooten, Kris Covens, et al.. (2008). A genotypic assay for the amplification and sequencing of integrase from diverse HIV-1 group M subtypes. Journal of Virological Methods. 153(2). 176–181. 48 indexed citations
19.
Lynen, Lutgarde, Sopheak Thai, Paul De Munter, et al.. (2006). The Added Value of a CD4 Count to Identify Patients Eligible for Highly Active Antiretroviral Therapy Among HIV-Positive Adults in Cambodia. JAIDS Journal of Acquired Immune Deficiency Syndromes. 42(3). 322–324. 12 indexed citations
20.
Lynen, Lutgarde, et al.. (2006). Validation of Primary CD4 Gating as an Affordable Strategy for Absolute CD4 Counting in Cambodia. JAIDS Journal of Acquired Immune Deficiency Syndromes. 43(2). 179–185. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026